Mar 2 |
Are Investors Undervaluing MacroGenics, Inc. (NASDAQ:MGNX) By 48%?
|
Mar 1 |
MacroGenics to Participate in Upcoming Investor Conferences
|
Feb 29 |
Analysts Estimate MacroGenics (MGNX) to Report a Decline in Earnings: What to Look Out for
|
Feb 27 |
MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call
|
Feb 20 |
MacroGenics: Evaluating Its Buy Status After A 200% Surge On Prostate Cancer Prospects
|
Feb 15 |
MacroGenics: Trying To Build A Better Everything
|
Feb 2 |
MacroGenics (MGNX) Surges 6.8%: Is This an Indication of Further Gains?
|
Jan 15 |
The 3 Most Undervalued Biotech Stocks to Buy in January
|
Jan 8 |
MacroGenics to Participate in Upcoming Investor Conference
|
Dec 20 |
MacroGenics stock climbs 13% in wake of upgrade by Citi
|